Articles On Genetic Technologies (ASX:GTG)

Wall Street falls amid Omicron uncertainty The US stock markets fell for the third consecutive day, as the S&P 500 had its biggest three day drop since September. All three major benchmarks fell – the S&P 500 by 1.14%, the Dow Jones...

The ASX started the week lower as a result of a drop in the energy and financial sectors. Energy shares fell by over 3%, as surging cases of the Omicron variant raised fears that new restrictions may hit fuel demand. Financials meanwhile we...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The ASX lost ground on Wednesday, as the banks struggled and the US dollar strengthened as markets continue to assess the prospect of tighter monetary policy and its potential effect on asset prices. Commonwealth Bank (ASX:CBA) tanked in th...

Local stocks posted a solid session on Wednesday ahead of this week’s main event on global markets later tonight — the US Fed’s latest policy decision. After plenty of forward guidance, the Fed is expected to formally announce the taper of...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ASX got off to a solid start today but the rally eased following the release of inflation data. Core inflation rose at the fastest pace since 2015 leading to speculation that the tightening of monetary policy could come sooner than 2024...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ASX finished in the green by just 0.03%. Today’s gain was spurred by a 1.34% rally in tech shares as well as a rally in Crown (ASX:CWN) shares in the wash-up of the Victorian government’s royal commission. Despite the report finding the...

On a day Facebook was out for 6 hours, the tech sector – in Australia and abroad – was sold off and that was enough to send the ASX into negative territory. The ASX 200 closed 0.41% down at 7,248 points and tech was easily the worst sector,...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ASX had a positive start to the week, driven by financial and travel stocks, despite global markets being overshadowed by the latest developments in the Evergrande saga. Evergrande’s shares in Hong Kong were suspended from trading after...

Leading the health stocks today is Genetic Technologies (ASX:GTG) which rose 14.28% after announcing a material increase in cash receipts for the September quarter to $850,000 from $68,000 in the June quarter. The company says the increase...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Once again the energy sector determined the direction of the market but unlike yesterday where it gained, today it finished in the red. The ASX 200 retreated 0.27% to close at 7,417 points, although the ASX Emerging Companies Index rose 1.3...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Local stocks tracked higher on Friday in a relatively calm session to end the week. The ASX200 traded flat, edging higher by 0.36% into the close. Those gains were comfortably outpaced by the small end of town, as the microcap Emerging Comp...

The ASX had another positive day but, unlike yesterday, held momentum to close at an all time high. The ASX 200 closed at 7,511 points which was an 0.11% gain although the ASX Emerging Companies Index fell 0.63% to 2,226 points. The top sec...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The ASX rebounded from yesterday’s losses but short of an all time high. The ASX 200 closed at 7,503 points, 0.38% up from yesterday but 6 points behind its intraday high. Meanwhile the ASX Emerging Companies Index gained 0.63% at 2,240 poi...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

The ASX finished Hump Day nearly a third of one per cent higher. The ASX 200 closed at 7,355 which is 0.31 per cent higher than yesterday while the ASX Emerging Companies Index closed 0.14 per cent higher at 2,193. It was a mostly positive...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Point of care diagnostic test provider Lumos Diagnostics (ASX:LDX) is set to list on the ASX on July 5. The company was founded in Melbourne in 2015 and is still headquartered there but has manufacturing facilities in California and Florida...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Small caps have dipped for a second straight day following their seven-day winning streak. The Small Ordinaries index closed yesterday down 12.1 points, or 0.37 per cent, to 3,278.8. Larger companies fared a little bit better, with the ASX2...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

It was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies releasing seperate announcements that sent their share prices higher. Cancer therapy stocks Invion (ASX:IVX), Immutep (ASX:IMM), and Imugene (ASX...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Molecular diagnostics company Genetic Technologies (ASX:GTG)  has announced the appointment of Michael Tonroe as its new chief financial officer.

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Summary ikeGPS (ASX:IKE) entered into a deal with Visual Globe’s AI platform to acquire its certain assets for the global communications and the electric utility market. The deal includes an initial payment of US$3.3 million in cash an...

04 Jan 2021 - Genetic Technologies (ASX:GTG) has appointed Simon Morriss to the role of Chief Executive Officer.

While genetic testing has gained immense popularity for its ability to diagnose monogenic mutations, experts believe that Polygenic Risk Score (PRS) is the future of predictive testing. Unlike genetic testing that captures only inherited di...

A quick wrap of the ASX’s key winners and losers on Tuesday, August 25. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 782 stocks rose, 682 declined and...

By Tim Boreham, Editor, The New Criterion The ASX biotechs surfing the COVID-19 story Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life sciences stocks across the d...